Thrombogenicity of β2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster

Blood

Volumn 101, Issue 1, 2003, Pages 157-162

  Jankowski, Milosz ^a   Vreys, Ingrid ^a   Wittevrongel, Christine ^a   Boon, Doris ^a   Vermylen, Jos ^a   Hoylaerts, Marc F ^a   Arnout, Jef ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN FC FRAGMENT; LUPUS ANTICOAGULANT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 11E8; MONOCLONAL ANTIBODY 5H2; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTERY THROMBOSIS; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CROSS REACTION; DISEASE MODEL; DOSE RESPONSE; HAMSTER; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; THROMBOGENESIS; THROMBOGENICITY;

EID: 0037217897     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-05-1310     Document Type: Article

References (40)

1. Love PE, Santoro SA. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non SLE disorders. Ann Intern Med. 1990;112:682-698.
2. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum. 1999;43:1309-1311.
3. Feinstein DI, Rapaport SI. Acquired inhibitors of blood coagulation. Prog Hemost Thromb. 1972;1:75-95.
4. Brandt JT, Triplett DA, Alvong B, Sharrer I. Criteria for diagnosis of lupus anticoagulant: An update. Thromb Haemost. 1995;74:1185-1190.
5. Harris EN, Gharavi AE, Boey ML, et al. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983;2:1211-1214.
6. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): Standardization and quantitation of results. Clin Exp Immunol. 1985;62:738-745.
7. Arnout J, Huybrechts E, Vanrusselt M, Falcon C, Vermylen J. Detection of lupus-like anticoagulants by an enzyme-linked immunosorbent assay using a partial thromboplastin as antigen: A comparative study. Thromb Haemost. 1990;64:26-31.
8. McNeil HP, Simpson RJ, Chestermal CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipidbinding inhibitor of coagulation: Beta-2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A. 1990;87:4120-4124.
9. Galli M, Confurmius P, Maasen C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990;335:1544-1547.
10. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet. 1990;336:177-178.
11. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RF. Lupus anticoagulants IgGs (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost. 1991;66:629-632.
12. Roubey RAS. Update on antiphospholipid antibodies. Curr Opin Rheumatol. 2000;12:374-378.
13. 2-glycoprotein I complexes to lipid membranes. Biochemistry. 1996;35:13833-13842.
14. 2GPI binding to phospholipids. J Clin Invest. 1997;99:2260-2268.
15. Arnout J, Wittevrongel C, Vanrusselt M, Hoylaerts M, Vermylen J. Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody-beta-2-glycoprotein I complexes on phospholipid surfaces. Thromb Haemost. 1998;79:79-86.
16. Field SL, Chesterman CN, Dai YP, Hogg PJ. Lupus antibody bivalency is required to enhance prothrombin binding to phospholipid. J Immunol. 2001;166:6118-6125.
17. Amengual A, Atsumi T, Khamashta MA, Hughes GRV. The role of tissue factor pathway in the hypercoagulable state in the patients with antiphospholipid syndrome. Thromb Haemost. 1998;79:276-281.
18. Musial J, Swadzba J, Jankowski M, Grzywacz M, Bazan-Socha S, Szczeklik A. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies. Thromb Haemost. 1997;78:1173-1177.
19. Rand JH. Molecular pathogenesis of the antiphospholipid syndrome. Circ Res. 2002;90:29-37.
20. Wahl DG, Guillemin F, de Maistre E, Perret C, Lecompte T, Thibaut G. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus - A meta-analysis. Lupus. 1997;6:467-473.
21. Wahl DG, Guillemin F, de Maistre E, Perret-Guillaume C, Lecompte T, Thibaut G. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus. 1998;7:15-22.
22. Arnout J. The pathogenesis of antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb Haemost. 1996;75:536-541.
23. Vermylen J, Hoylaerts MF, Arnout J. Antibodymediated thrombosis. Thromb Haemost. 1997;78:420-426.
24. Umemura K, Wada K, Uematsu T, Nakashima M. Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model. Stroke. 1993;24:1077-1081.
25. Kawasaki T, Kaida T, Arnout J, Vermylen J, Hoylaerts MF. A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic. Thromb Haemost. 1999;81:306-311.
26. Ey PL, Prowse SJ, Jenkin CR. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose. Immunochemistry. 1978;15:429-436.
27. Arnout J, Vanrusselt M, Huybrechts E, Vermylen J. Optimisation of the dilute prothrombin time for the detection of the lupus anticoagulant by use of a recombinant tissue thromboplastin. Br J Haematol. 1994;87:94-99.
28. Stockmans F, Stassen JM, Vermylen J, Hoylaerts MF, Nystrom A. A technique to investigate mural thrombosis in small arteries and veins, I: comparative morphometric and histological analysis. Ann Plast Surg. 1997;38:56-62.
29. Ginsburg KS, Liang MH, Newcomer L, et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med. 1992;117:997-1002.
30. Ginsberg JS, Wells PS, Brill-Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood. 1995;86:3685-3691.
31. Pierangeli SS, Barker JH, Sitkovac D, et al. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost. 1994;71:670-674.
32. Pierangeli SS, Liu X, Barker JH, Anderson G, Harris EN. Induction of thrombosis in mouse model by IgG, IgM and IgA immunoglobulins from patients with antiphospholipid syndrome. Thromb Haemost. 1995;74:1361-1367.
33. Olee T, Pierangeli SS, Handley HH, et al. A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice. Proc Natl Acad Sci U S A 1996;93:8606-8611.
34. 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies. Circulation 1996;94:1746-1751.
35. 2Gp1) alone. Lupus 1998;7:341-346.
36. Nemmar A, Hoylaerts MF, Verbeken E, Hoet PHM, Nemery B. Ultrafine particles affect experimental thrombosis in vivo. Am J Resp Crit Care Med. 2002;166:998-1004.
37. Pierangeli SS, Espinola R, Liu X, Harris EN, Salmon JE. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype. Arthritis Rheum. 2001;44:876-883.
38. Pierangeli SS, Colden-Stanfield M, Liu X, Barker JH, Anderson GL, Harris EN. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation. 1999;99:1997-2002.
39. Lutters BC, Meijers JC, Derksen RH, Arnout J, de Groot PG. Dimers of beta-2-glycoprotein I mimic the in vitro effects of beta-2-glycoprotein I-anti-beta-2-glycoprotein I antibody complexes. J Biol Chem. 2001;276:3060-3067.
40. 2-glycoprotein I: structure and function [abstract]. Thromb Haemost 2001;(suppl):SY925.